Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension

Proceedings of the American Thoracic Society

Volumn 3, Issue 7, 2006, Pages 571-576

  Galiè, Nazzareno ^a   Kim, Nick H S ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

Hypertension; Pulmonary; Pulmonary embolism

Indexed keywords

AORTA ARCH SYNDROME; ARTERY COMPLIANCE; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; CLINICAL FEATURE; CLINICAL RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; EISENMENGER COMPLEX; ENDOTHELIAL DYSFUNCTION; HISTOPATHOLOGY; HUMAN; LUNG BLOOD VESSEL; LUNG PERFUSION; LUNG VASCULAR RESISTANCE; MICROANGIOPATHY; PATHOGENESIS; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; SHEAR STRESS; SURGICAL PATIENT; THROMBOEMBOLISM; TISSUE SECTION;

HUMANS; HYPERTENSION, PULMONARY; MICROCIRCULATION; PULMONARY CIRCULATION; PULMONARY EMBOLISM; VASCULAR DISEASES;

EID: 33748765846     PISSN: 15463222     EISSN: 15463222     Source Type: Journal    
DOI: 10.1513/pats.200605-113LR     Document Type: Conference Paper

References (47)

1. Jamieson SW, Kapelanski DP. Pulmonary endarterectomy. Curr Probl Surg 2000;37:165-252.
2. Dartevelle P, Fadel E, Mussot S, Chapelier A, Herve P, de Perrot M, Cerrina J, Ladurie FL, Lehouerou D, Humbert M, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637-648.
3. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, Kapelanski DP, Watt CN, Moser KM. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999;160:523-528.
4. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003;76:1457-1462.
5. Fedullo PF, Auger WR, Channick RN, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2001;22:561-581.
6. Fedullo PF, Rubin LJ, Kerr KM, Auger WR, Channick RN. The natural history of acute and chronic thromboembolic disease: the search for the missing link. Eur Respir J 2000;15:435-437.
7. Hoeper MM, Mayer E, Simonneau G, Rubin L. Chronic thromboembolic pulmonary hypertension. Circulation 2006;113:2011-2020.
8. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993;103:685-692.
9. Azarian R, Wartski M, Collignon MA, Parent F, Herve P, Sors H, Simonneau G. Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med 1997;38:980-983.
10. Yi ES, Kim H, Ahn H, Strother J, Morris T, Masliah E, Hansen LA, Park K, Friedman PJ. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension: a morphometric and immunohistochemical study. Am J Respir Crit Care Med 2000;162:1577-1586.
11. Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J 2000;15:440-448.
12. Moser KM, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J 1992;5:334-342.
13. Thistlethwaite PA, Mo M, Madani MM, Deutsch R, Blanchard D, Kapelanski DP, Jamieson SW. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2002;124:1203-1211.
14. Kim NHS. Assessment of operability in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:584-588.
15. Moser KM, Braunwald NS. Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension. Chest 1973;64:29-35.
16. Fadel E, Mazmanian GM, Baudet B, Detruit H, Verhoye JP, Cron J, Fattal S, Dartevelle P, Herve P. Endothelial nitric oxide synthase function in pig lung after chronic pulmonary artery obstruction. Am J Respir Crit Care Med 2000;162:1429-1434.
17. Heath D, Smith P, Gosney J, Mulcahy D, Fox K, Yacoub M, Harris P. The pathology of the early and late stages of primary pulmonary hypertension. Br Heart J 1987;58:204-213.
18. Smith P, Heath D, Yacoub M, Madden B, Caslin A, Gosney J. The ultrastructure of plexogenic pulmonary arteriopathy. J Pathol 1990;160:111-121.
19. Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, Reid LM, Tuder RM. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43:S25-S32.
20. Wagenvoort CA. Lung biopsies and pulmonary vascular disease. In: Weir EK, Reeves JT, editors. Pulmonary hypertension. Mount Kisco, NY: Futura Publishing Co; 1984. pp. 393-438.
21. Reid LM. Structure and function in pulmonary hypertension: new perceptions. Chest 1986;89:279-288.
22. Fishman AP. The pulmonary circulation. In: Fishman AP, Elias JA, Fishman JA, Grippi, MA, Kaiser LR, Senior RM, editors. Pulmonary diseases and disorders, 3rd ed. New York: McGraw-Hill; 1998. pp. 1233-1250.
23. Arbustini E, Morbini P, D'Armini AM, Repetto A, Minzioni G, Piovella F, Vigano M, Tavazzi L. Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart 2002;88:177-182.
24. Anderson EG, Simon G, Reid L. Primary and thromboembolic pulmonary hypertension: and quantitative pathological study. J Pathol 1972;110:273-293.
25. Fadel E, Michel RP, Eddahibi S, Bernatchez R, Mazmanian GM, Baudet B, Dartevelle P, Herve P. Regression of postobstructive vasculopathy after revascularization of chronically obstructed pulmonary artery. J Thorac Cardiovasc Surg 2004;127:1009-1017.
26. Kim H, Yung GL, Marsh JJ, Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN. Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase. Exp Lung Res 2000;26:287-301.
27. Hirsch AM, Moser KM, Auger WR, Channick RN, Fedullo PF. Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence? Am J Respir Crit Care Med 1996;154:491-496.
28. Chaouat A, Weitzenblum E, Higenbottam T. The role of thrombosis in severe pulmonary hypertension. Eur Respir J 1996;9:356-363.
29. Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, Simonneau G. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000;15:395-399.
30. Lang IM, Kerr K. Risk factors for CTEPH. Proc Am Thorac Soc 2006;3:568-570.
31. Lang IM, Marsh JJ, Olman MA, Moser KM, Schleef RR. Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli. Circulation 1994;90:706-712.
32. Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation 1992;86:1241-1248.
33. Benotti JR, Ockene IS, Alpert JS, Dalen JE. The clinical profile of unresolved pulmonary embolism. Chest 1983;84:669-678.
34. Torbicki A, van Beek EJR, Charbonnier B, Meyer G, Morpurgo M, Palla A, Terrier A, Galie N, Gorge G, Herold C, et al. for Task Force on Pulmonary Embolism, European Society of Cardiology (ESC). Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000;21:1301-1336.
35. Bonderman D, Turecek PL, Jakowitsch J, Weltermann A, Adlbrecht C, Schneider B, Kneussl M, Rubin LJ, Kyrle PA, Klepetko W, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 2003;90:372-376.
36. Kimura H, Okada O, Tanabe N, Tanaka Y, Terai M, Takiguchi Y, Masuda M, Nakajima N, Hiroshima K, Inadera H, et al. Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2001;164:319-324.
37. Kim H, Yung GL, Marsh JJ, Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN. Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension. Eur Respir J 2000;15:640-648.
38. Bauer M, Wilkens H, Langer F, Schneider SO, Lausberg H, Schafers HJ. Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation 2002;105:1034-1036.
39. Reesink HJ, Lutter R, Kloek JJ, Jansen HM, Bresser P. Hemodynamic correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;24:110s.
40. Coulden R. State of the art imaging techniques in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:577-583.
41. Kafi SA, Melot C, Vachiery JL, Brimioulle S, Naeije R. Partitioning of pulmonary vascular resistance in primary pulmonary hypertension. J Am Coll Cardiol 1998;31:1372-1376.
42. Fesler P, Pagnamenta A, Vachiery JL, Brimioulle S, Abdel Kafi S, Boonstra A, Delcroix M, Channick RN, Rubin LJ, Naeije R. Single arterial occlusion to locate resistance in patients with pulmonary hypertension. Eur Respir J 2003;21:31-36.
43. Kim NH, Fesler P, Channick RN, Knowlton KU, Ben-Yehuda O, Lee SH, Naeije R, Rubin LJ. Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation 2004;109:18-22.
44. Bresser P, Pepke-Zaba J, Jais X, Humbert M, Hoeper MM. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm. Proc Am Thorac Soc 2006.
45. Rubin L, Hoeper M, Klepetko W, Galiè N, Lang I, Simonneau G. Current and future management of chronic thromboembolic pulmonary hypertension: from diagnosis to treatment responses. Proc Am Thorac Soc 2006.
46. Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S, Nakanishi N. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003;123:338-343.
47. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003;167:1139-1141.